Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted delivery of a therapeutic entity using complementary oligonucleotides

Targeted delivery of a therapeutic entity using complementary oligonucleotides

US Patent 5733523 · Granted Mar 31, 1998

Estimated economic value: $1,004,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antithrombotic dual inhibitors comprising a biotin residue2013
Anticoagulant antithrombotic dual inhibitors comprising a biotin label2012
Antithrombotic dual inhibitors comprising a biotin residue2012
Conjugates of a polypeptide and a pentasaccharide2012
Synthetic polysaccharides, process for their preparation and pharmaceutical comp2011
Antithrombotic compound2009
Antithrombotic compound2005
Heterocyclic derivatives and their use as antithrombotic agents2004
Synthetic polysaccharides, preparation method therefor and pharmaceutical compos2003
Synthetic polysaccharides, their method of production and pharmaceutical composi2003
Antithrombotic compounds2002
Heterocyclic derivatives and their use as antithrombotic agents2002